Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

101.45

-2.88 (-2.76%)

At close: Sep 16, 2026, 4:00 PM EDT

100.75

-0.70 (-0.69%)

After-hours: Sep 16, 2026, 6:26 PM EDT

Monopar Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	681	436	134	5	31	40
Market Cap Growth	124.23%	225.25%	2552.79%	-83.48%	-24.23%	-42.34%
Enterprise Value	547	293	128	-3	16	18
Last Close Price	104.33	65.30	22.00	1.70	11.85	16.05

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PB Ratio	5.35	3.17	2.44	0.91	3.04	2.13
P/TBV Ratio	5.22	3.17	2.44	0.91	3.04	2.13

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.00	0.00	-	-	0.00	-
Net Debt / Equity Ratio	-1.02	-1.02	-1.09	-1.30	-1.30	-1.07
Quick Ratio	33.44	51.33	11.46	4.14	4.19	12.85
Current Ratio	33.56	51.35	11.48	4.17	4.21	12.98
Return on Equity (ROE)	-19.50%	-14.22%	-51.42%	-107.19%	-72.45%	-52.57%
Return on Assets (ROA)	-14.64%	-10.39%	-29.87%	-53.66%	-39.03%	-30.51%
Return on Capital Employed (ROCE)	-16.90%	-12.10%	-29.40%	-158.00%	-104.30%	-48.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-2.61%	-3.14%	-11.62%	-166.13%	-34.34%	-22.52%
Buyback Yield / Dilution	-45.84%	-95.53%	-37.09%	-8.70%	-1.97%	-13.82%

SEC Filings: 10-K · 10-Q